A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.

A new study finds that intrauterine instillation of 2% mepivacaine significantly lowers pain levels during intrauterine device placement.

A systematic review highlights increased risks of congenital anomalies in very young and advanced maternal age groups, emphasizing the need for enhanced screening in these populations.

A recent study suggests the ketogenic diet could positively impact menstrual cycles by boosting ketones, potentially unlocking new therapeutic insights for women’s reproductive health.

A study found that migraine-related disability worsens health-related quality of life, with gender-specific differences, particularly affecting women with mild disability.

In a recent study, increased rates of spinal hypotension were observed among women receiving a higher plain ropivacaine dose during cesarean section.

The findings of the study suggest HS is associated with pregnancy complications and adverse outcomes for both mothers and offspring.

Persistent hot flashes and/or night sweats are significantly linked to up to a 50% increased risk of developing diabetes.

The March of Dimes 2024 report reveals a troubling D+ grade for US preterm births, with significant racial and socioeconomic disparities fueling an urgent need for better prenatal care and targeted interventions.

A meta analysis highlights how kinesiotherapy post-breast cancer surgery may significantly improve patient quality of life.

In a recent study, a high polycystic ovary syndrome was found among reproductive-aged women in India, with phenotype C being predominant.

HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.

A population-based time-series analysis California before, during and after legalization show a rising trend in women using cannabis while pregnancy especially when the state has legalized the drug.

In a recent study, similar postoperative outcomes were reported in patients receiving anterior vaginal wall repair vs paravaginal repair for laparoscopic pelvic organ prolapse, including similar success rates.

Panama’s switch to the 9-valent HPV vaccine promises greater protection and reduced cancer rates, preventing thousands of HPV-related cases and deaths.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Learn why postpartum hemorrhage remains a critical maternal health issue in the United States and discover effective treatment approaches and preventative strategies shared by expert ob-gyn Kameelah Phillips, MD.

In a recent study, researchers recommended minimally invasive procedures vs hysterectomy for improved patient outcomes when treating uterine fibroids.

In a recent study, successful pregnancy termination was reported when performing medical abortion early vs delayed, with similar safety outcomes also observed.

In a recent study, stress urinary incontinence outcomes were improved in women utilizing pressure-mediated biofeedback vs pelvic floor muscle training alone.

A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.

Data has indicated adverse maternal and neonatal outcomes from placental conditions, alongside a high risk of recurrence in subsequent pregnancies.

In a recent study, menopausal women with frequent and time-consistent vasomotor symptoms were more likely to develop diabetes than those with reduced vasomotor symptoms.

In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.

Rossella Nappi, MD, PhD, highlights how fezolinetant rapidly reduces the severity and frequency of hot flashes, offering a personalized, non-hormonal solution for menopausal women.